跳到主要內容

Perceptive Advisors LLC

SEC CIK
0001224962
最新申報
2026/8/14

2022 年第 1 季持倉

持倉截至 2022/3/31,2022/5/16 申報。只含多頭部位,變化是跟 2021 年第 4 季比股數。

機構總覽
持股檔數
135
較 2021 年第 4 季 −10
總值
$48.1 億
較 2021 年第 4 季 −$16.6 億 (−25.6%)
申報日
2022/5/16
SEC
Perceptive Advisors LLC 在 2022 年第 1 季的持倉
證券類別股數市值佔組合 %股數變化動作紀錄
BBIOBridgeBio Pharma, Inc.COM3,839,380$3,897 萬0.8%−3,289,375−46.1%減碼歷史
NAUTNautilus Biotechnology, Inc.COM9,111,151$3,954 萬0.8%00.0%不變歷史
INBXInhibrx Biosciences, Inc.COM1,781,235$3,969 萬0.8%+437,745+32.6%加碼歷史
CINCCinCor Pharma, Inc.COM2,319,117$4,068 萬0.8%+2,319,117新進歷史
ChemoCentryx, Inc.16383L106COM1,655,079$4,149 萬0.9%+239,633+16.9%加碼–
ALDXAldeyra Therapeutics, Inc.COM9,903,879$4,402 萬0.9%00.0%不變歷史
Coherus Biosciences Inc19249HAB9NOTE 1.500% 4/1–$4,460 萬0.9%–––
LONALeonaBio, Inc.COM3,425,916$4,625 萬1.0%00.0%不變歷史
TVTXTravere Therapeutics, Inc.COM1,845,555$4,756 萬1.0%00.0%不變歷史
CCCCC4 Therapeutics, Inc.COM STK2,082,723$5,053 萬1.0%−126,190−5.7%減碼歷史
PRCTPROCEPT BioRobotics CorpCOM1,488,284$5,208 萬1.1%+159,999+12.0%加碼歷史
Bellus Health Inc New07987C204COM NEW8,136,630$5,598 萬1.2%+491,396+6.4%加碼–
RLAYRelay Therapeutics, Inc.COM1,943,097$5,816 萬1.2%00.0%不變歷史
CHRSCoherus Oncology, Inc.COM4,695,848$6,062 萬1.3%−711,950−13.2%減碼歷史
RAPTRAPT Therapeutics, Inc.COM2,799,962$6,157 萬1.3%−127,603−4.4%減碼歷史
ALBOAlbireo Pharma, Inc.COM2,360,139$7,040 萬1.5%00.0%不變歷史
XENEXenon Pharmaceuticals Inc.COM2,411,447$7,372 萬1.5%00.0%不變歷史
APLSApellis Pharmaceuticals, Inc.COM1,481,700$7,529 萬1.6%+30,000+2.1%加碼歷史
OMOutset Medical, Inc.COM1,883,399$8,551 萬1.8%+20,002+1.1%加碼歷史
VBIVVBI Vaccines Inc/BCCOM NEW52,335,002$8,688 萬1.8%00.0%不變歷史
ISEEIVERIC bio, Inc.COM5,225,415$8,794 萬1.8%−1,254,585−19.4%減碼歷史
Collegium Pharmaceutical, Inc19459JAA2NOTE 2.625% 2/1–$8,947 萬1.9%–––
RXDXPrometheus Biosciences, Inc.COM2,440,582$9,216 萬1.9%−732,203−23.1%減碼歷史
MGTXMeiraGTx Holdings plcCOM6,948,277$9,620 萬2.0%00.0%不變歷史
CRNXCrinetics Pharmaceuticals, Inc.COM5,163,517$1.13 億2.4%00.0%不變歷史
GBTGlobal Blood Therapeutics, Inc.COM3,892,493$1.35 億2.8%+442,578+12.8%加碼歷史
HZNPHorizon Therapeutics Public Ltd CoSHS1,357,903$1.43 億3.0%−380,237−21.9%減碼歷史
CERECerevel Therapeutics Holdings, Inc.COM5,086,727$1.78 億3.7%00.0%不變歷史
MRTXMirati Therapeutics, Inc.COM2,380,710$1.96 億4.1%−903,073−27.5%減碼歷史
IOVAIovance Biotherapeutics, Inc.COM12,201,261$2.03 億4.2%+2,073,320+20.5%加碼歷史
LIANYLianBioSPONSORED ADS56,319,960$2.09 億4.3%00.0%不變歷史
SWTXSpringWorks Therapeutics, Inc.COM4,527,993$2.56 億5.3%−321,919−6.6%減碼歷史
FOLDAmicus Therapeutics, Inc.COM27,555,845$2.61 億5.4%+996,402+3.8%加碼歷史
Travere Therapeutics, Inc.89422GAA5NOTE 2.250% 3/0–$4.74 億9.8%–新進–
AGRXAgile Therapeutics IncCOM21,294,485––00.0%不變歷史

2021 年第 4 季之後清倉(24 檔)

2021 年第 4 季季末還持有、這份申報已經沒有的部位。

Perceptive Advisors LLC 在 2021 年第 4 季之後清倉的部位
證券類別2021 年第 4 季股數2021 年第 4 季市值2021 年第 4 季佔組合 %紀錄
Retrophin Inc761299AB2NOTE 2.500% 9/1–$4.85 億7.5%–
BMRNBiomarin Pharmaceutical IncCOM1,180,000$1.04 億1.6%歷史
Nevro Corp64157FAC7NOTE 2.750% 4/0–$1.02 億1.6%–
ARNAArena Pharmaceuticals IncCOM NEW500,000$4,647 萬0.7%歷史
KODKodiak Sciences Inc.COM520,152$4,410 萬0.7%歷史
UTHRUnited Therapeutics CorpCOM94,064$2,033 萬0.3%歷史
VTRSViatris IncStock1,004,419$1,359 萬0.2%歷史
BCABBioAtla, Inc.COM661,200$1,298 萬0.2%歷史
IMCRImmunocore Holdings plcADS360,000$1,233 萬0.2%歷史
BIIBBiogen Inc.COM48,600$1,166 萬0.2%歷史
HRMYHarmony Biosciences Holdings, Inc.COM239,258$1,020 萬0.2%歷史
ADPTAdaptive Biotechnologies CorpCOM352,804$990.0 萬0.2%歷史
KYMRKymera Therapeutics, Inc.COM155,000$984.1 萬0.2%歷史
ONEM1Life Healthcare IncCOM532,350$935.3 萬0.1%歷史
CLDXCelldex Therapeutics, Inc.COM NEW229,807$888.0 萬0.1%歷史
EQRXEQRx, Inc.COM1,250,000$852.5 萬0.1%歷史
TBIOTelesis Bio Inc.COM425,000$459.0 萬0.1%歷史
Achilles Therapeutics PLC00449L102SPONSORED ADS755,375$378.4 萬0.1%–
AXSMAxsome Therapeutics, Inc.COM80,420$303.8 萬<0.1%歷史
PMVPPMV Pharmaceuticals, Inc.COM125,000$288.8 萬<0.1%歷史
YARWYarrow Bioscience, Inc.COM2,178,022$222.2 萬<0.1%歷史
ITOSiTeos Therapeutics, Inc.COM20,000$93.1 萬<0.1%歷史
EIGREiger BioPharmaceuticals, Inc.COM139,890$72.6 萬<0.1%歷史
PHVSPharvaris N.V.COM27,000$38.9 萬<0.1%歷史